Entest Biomedical, Inc.t CEO Blogcast Today at 10:00 am Covering Strategic Rollout of ImenVax(TM) -- an Immuno-Therapeutic Cancer Vaccine for Dogs

SAN DIEGO, Sept. 21, 2010 (GLOBE NEWSWIRE) -- Entest BioMedical, Inc. (OTCBB:ENTB) announced that Chairman and CEO David Koos will be hosting a blogcast today, September 21, 2010 at 10:00 am PDT. Discussion will focus on developments related to the Company's immuno-therapeutic cancer vaccine for dogs, ImenVax™.
MORE ON THIS TOPIC